Clinical Trial Update: SGLT2i and Incretin and CRTd. [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating SGLT2 inhibitors and incretin-based therapy in patients with type 2 diabetes mellitus and heart failure, in conjunction with CRT-D; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• SGLT2 inhibitors (SGLT2 inhibitor)
• incretin therapy (incretin-based therapy (GLP-1 receptor agonists and/or DPP-4 inhibitors))

Snippet

Sponsor: University of Campania Luigi Vanvitelli | Conditions: Type 2 Diabetes Mellitus, Heart Failure | Phase 4 | Status: COMPLETED